Mitolactol chemotherapy for malignant melanoma: a phase II study.

  • 1 July 1984
    • journal article
    • Vol. 68, 1045-6
Abstract
Fifty-one patients (43 evaluable) with malignant melanoma were treated with mitolactol in an intermittent oral schedule. There were four objective tumor responses, all occurring in patients previously treated with dacarbazine.

This publication has 0 references indexed in Scilit: